Representative Director, President & CEO
Yoichi Okumura served as the Global IP Head of Takeda Pharmaceutical Co., Ltd., (head of intellectual property department), President of INTERPAT, an international intellectual property association of pharmaceutical companies, and Chief Director of the Japan Intellectual Property Association (JIPA). He is one of the leading experts on intellectual property in the pharmaceutical industry. He has extensive experience in overseas business development, including acquisition of many assets and companies.
He holds an MSc in Pharmacy from Gifu Pharmaceutical University and LLM from Kobe University. Pharmacist.
Executive Director & Senior Science Fellow
Yukio Yamada previously served as the Cardiovascular & Metabolic Disease Drug Discovery Unit Head at Takeda Pharmaceutical Co., Ltd. He has extensive experience in the cardiovascular and metabolic area, including the creation successful launch of multiple clinical compounds, the development of clinical assets, licenses, and joint research.
He graduated from the Faculty of Agriculture, Kyushu University, holds an MSc in Agriculture from Kyushu University, and a PhD in Medical Science from Osaka University.
Executive Director & CFO
Keiichi Kiyota has more than 20 years of management history at biotech companies and has seen an initial public offering as a Chief Financial Officer. He has experience in corporate management as practical personnel including equity finance, organization growth strategy, and establishment of internal control.
He graduated from the Faculty of Agriculture, Meiji University, and holds an MBA from Hosei University.
Executive Managing Director, INCJ, Ltd.
Koichi Ashida has established a venture capital firm specializing in healthcare, with his career based in strategic consulting companies and pharmaceutical companies. He has invested in many biotech companies, achieving multiple M&A and initial public offerings.
He holds an MSc in Biological Science from the University of Tokyo.
Director, INCJ, Ltd.
Takehiko Sawabe has been engaged in investment activities and post-investment support for health and medical companies as a venture capitalist, with his career based in R&D and business development at pharmaceutical and healthcare companies.
He holds an MSc in Pharmacy from the University of Tokyo and an MBA from the Graduate School of Management, Globis University.
Full-time Audit & Supervisory Committee Member
Toshiaki Kudo’s strengths lie in his more than 25 years of practical experience at pharmaceutical companies, including drug discovery research, development, planning, and audit. He served the company as the team head of the research department, and as head of the administration department.
He holds an MSc and PhD in Science from Tohoku University.
Audit & Supervisory Committee Member
Tsuyoshi Dai has served as an outside director at several listed companies including biotech ventures. He has a background in corporate legal affairs such as intellectual properties, bankruptcy proceedings, turnaround support, dispute, and litigation for pharmaceutical, medical, biotechnology and healthcare companies.
He graduated from Keio University. Lawyer.
Audit & Supervisory Committee Member
After working for a Big 4 accounting firm, Kenji Maekawa established his own office, mainly providing advisory services for life science and pharmaceutical companies.
He has extensive experience such as support for business startups and fundraising, as well as audit and advisory services for IFRS introduction and an internal control reporting system (J-SOX).
He graduated from the Faculty of Life Science and Technology, Tokyo Institute of Technology, holds an MSc in Science and Technology from the Tokyo Institute of Technology.
Certified Public Accountant.